Pentoxifylline 400mg ER Tablets
Overview
What is this medicine?
How to Use This Medicine
To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. Take your medication with meals to help your body absorb it properly. Swallow the tablet whole - do not chew, break, or crush it. Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better.
Storing and Disposing of Your Medication
Store your medication at room temperature, away from light and moisture. Keep it in a dry place, such as a closet or drawer, and avoid storing it in the bathroom. Keep all medications out of the reach of children and pets to ensure their safety. If you have unused or expired medication, dispose of it properly. Do not flush it down the toilet or pour it down the drain unless instructed to do so by your pharmacist. Check with your pharmacist for guidance on the best way to dispose of your medication, and consider participating in a drug take-back program in your area.
What to Do If You Miss a Dose
If you miss a dose, take it as soon as you remember, with a meal. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for a missed one.
Lifestyle & Tips
- Take this medication with meals to reduce stomach upset.
- Swallow the extended-release tablets whole; do not crush, chew, or break them.
- It may take several weeks (e.g., 2-4 weeks) to notice an improvement in your symptoms. Continue taking the medication as prescribed.
- Smoking cessation is crucial for improving peripheral artery disease and maximizing the benefits of this medication.
- Regular exercise, as tolerated and recommended by your doctor, is also important for managing intermittent claudication.
Available Forms & Alternatives
Available Strengths:
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Chest pain or pressure
An irregular heartbeat
Severe dizziness or fainting
Unexplained bruising or bleeding
Other Possible Side Effects
Like all medications, this drug can cause side effects. Although many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or persist, contact your doctor for advice:
Burping
Bloating
Gas
Upset stomach or vomiting
Dizziness or headache
Reporting Side Effects
This list is not exhaustive, and you may experience other side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Unusual bleeding or bruising
- Black, tarry stools or blood in urine
- Severe dizziness or fainting
- Chest pain or irregular heartbeat
- Severe nausea, vomiting, or stomach pain
- Allergic reaction (rash, itching, swelling, severe dizziness, trouble breathing)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have recently had a bleeding problem in your brain or in the retina of your eye.
* If you are unable to consume products containing theophylline, theobromine, or caffeine.
This list is not exhaustive, and it is crucial to discuss all your medications, including prescription and over-the-counter drugs, natural products, and vitamins, with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions.
Remember, do not start, stop, or change the dose of any medication without first consulting your doctor to ensure your safety.
Precautions & Cautions
Overdose Information
Overdose Symptoms:
- Flushing
- Hypotension (low blood pressure)
- Somnolence (drowsiness)
- Loss of consciousness
- Fever
- Agitation
- Seizures
- Nausea
- Vomiting
- Dizziness
- Tachycardia (fast heart rate)
What to Do:
Call 1-800-222-1222 (Poison Control Center) immediately or seek emergency medical attention. Treatment is generally supportive and symptomatic. Gastric lavage may be performed if ingestion is recent. Activated charcoal may be considered.
Drug Interactions
Major Interactions
Moderate Interactions
- Antihypertensive agents: Additive hypotensive effect, monitor blood pressure.
- Theophylline: Increased plasma levels of theophylline, leading to increased toxicity (nausea, vomiting, seizures).
- Cimetidine: May increase plasma concentrations of pentoxifylline and its metabolites, potentially increasing adverse effects.
Monitoring
Baseline Monitoring
Rationale: To establish a baseline for assessing treatment efficacy.
Timing: Prior to initiation of therapy.
Rationale: To monitor for potential hypotensive effects, especially in patients on antihypertensive medications.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Periodically (e.g., every 2-4 weeks initially, then every 3-6 months)
Target: Improvement in pain-free and maximal walking distance
Action Threshold: Lack of improvement after 8 weeks may indicate need to discontinue or re-evaluate.
Frequency: Periodically, especially during initial therapy or dose adjustments
Target: Maintain within patient's target range
Action Threshold: Significant hypotension or symptomatic orthostasis.
Frequency: Routinely, especially if co-administered with anticoagulants or antiplatelets
Target: Absence of abnormal bleeding
Action Threshold: Any signs of unusual bleeding.
Symptom Monitoring
- Dizziness
- Headache
- Nausea
- Vomiting
- Diarrhea
- Dyspepsia
- Abdominal discomfort
- Flushing
- Chest pain
- Arrhythmias
- Signs of bleeding (e.g., unusual bruising, nosebleeds, blood in stool/urine)
Special Patient Groups
Pregnancy
Pentoxifylline is classified as Pregnancy Category C. Animal studies have shown adverse effects on the fetus at doses higher than human therapeutic doses. There are no adequate and well-controlled studies in pregnant women. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.
Trimester-Specific Risks:
Lactation
Pentoxifylline and its metabolites are excreted in human breast milk. Due to the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother. Lactation Risk Category L3 (Moderately Safe).
Pediatric Use
Safety and effectiveness in pediatric patients have not been established. Not recommended for use in this population.
Geriatric Use
No specific dose adjustment is required based solely on age. However, elderly patients are more likely to have impaired renal or hepatic function, which may necessitate dose adjustments. Monitor for adverse effects and renal/hepatic function.
Clinical Information
Clinical Pearls
- Pentoxifylline is not a cure for peripheral artery disease (PAD) but can help manage symptoms of intermittent claudication.
- Full therapeutic effects may not be observed for 2-4 weeks, and some patients may require up to 8 weeks of therapy before significant improvement is noted.
- Patients should be advised to continue smoking cessation and exercise programs, as these are critical for managing PAD.
- Take with food to minimize gastrointestinal side effects.
- Do not crush or chew extended-release tablets.
- Monitor for signs of bleeding, especially in patients concurrently taking anticoagulants or antiplatelet agents.
Alternative Therapies
- Cilostazol (another phosphodiesterase inhibitor, often preferred for claudication)
- Supervised exercise therapy (first-line non-pharmacologic treatment)
- Antiplatelet agents (e.g., Aspirin, Clopidogrel - primarily for cardiovascular event risk reduction, not direct claudication symptom relief)
- Statins (for lipid management and cardiovascular risk reduction)
- Angioplasty or surgical revascularization (for severe cases)